HLA-DR Antibody (LN-3)

Western Blot: HLA-DR Antibody (LN-3) [NBP2-45310] - Flow Cytometry: HLA-DR Antibody (LN-3) - Azide and BSA Free [NBP2-34676] - Analysis using the PE conjugate of NBP2-34676. Staining of normal human peripheral blood cells with Mouse IgG2b K Isotype Control PE (blue histogram) or Anti-Human HLA-DR PE (purple histogram). Cells in the lymphocyte (left) or monocyte (right) gate were used for analysis.

Immunohistochemistry-Paraffin: HLA-DR Antibody (LN-3) [NBP2-45310] - Immunohistochemistry-Paraffin: HLA-DR Antibody (LN-3) - Azide and BSA Free [NBP2-34676] - Formalin-paraffin human tonsil stained with HLA-DR MAb (LN-3).

Flow Cytometry: HLA-DR Antibody (LN-3) [NBP2-45310] - Flow Cytometry: HLA-DR Antibody (LN-3) - Azide and BSA Free [NBP2-34676] - Analysis using the PE/Cy7 conjugate of NBP2-34676. Staining of HLA-DR in human buffy coat using anti-HLA-DR antibody. The primary antibody was used at a dilution of 1:100 and incubated for 25 min at 4C in 2% human serum, 0.5mM EDTA in DPBS. Image from verified customer review.

Immunohistochemistry-Paraffin: HLA-DR Antibody (LN-3) [NBP2-45310] - Human Tonsil stained with HLA-DRB Monoclonal Antibody (LN-3).

Immunohistochemistry-Paraffin: HLA-DR Antibody (LN-3) [NBP2-45310] - Human Histiocytoma stained with HLA-DRB Monoclonal Antibody (LN-3).

Flow Cytometry: HLA-DR Antibody (LN-3) [NBP2-45310] - Flow Cytometry: HLA-DR Antibody (LN-3) - Azide and BSA Free [NBP2-34676] - Analysis using the PE/Cy7 conjugate of NBP2-34676. Staining of normal human peripheral blood cells with staining buffer (autofluorescence) (open histogram) or Anti-Human HLA-DR PE-Cyanine7 (filled histogram). Cells in the lymphocyte (right) or monocyte (left) gate were used for analysis.

Flow Cytometry: HLA-DR Antibody (LN-3) [NBP2-45310] - Flow Cytometry: HLA-DR Antibody (LN-3) - Azide and BSA Free [NBP2-34676] - Analysis using the PerCP/Cy5.5 conjugate of NBP2-34676. Staining of normal human peripheral blood cells with Mouse IgG2b kappa Isotype Control PerCP-Cy5.5 (open histogram) or Anti-Human HLA-DR PerCP-Cy5.5 (filled histogram). Cells in the lymphocyte gate were used for analysis.

• Reactivity: Hu, Mk, Mu(-)
• Applications: WB, Flow, IHC, IHC-P, ICC/IF
• Clone: LN-3
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Concentration: 0.2 mg/ml

HLA-DR Antibody (LN-3) Summary

• Immunogen: Activated human peripheral blood mononuclear cells
• Localization: Cell Surface
• Specificity: This MAb reacts with a 28kDa chain of HLA-DRB1 antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. The L243 antibody recognizes a different epitope than the LN3 monoclonal antibody, and these antibodies do not cross-block binding to each other's respective epitopes. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kDa alpha (heavy) chain and a 28kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma.
• Isotype: IgG2b Kappa
• Clonality: Monoclonal
• Host: Mouse
• Gene: HLA-DRA
• Purity: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Western Blot 0.5 - 1.0 ug/ml
  • Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml
  • Immunohistochemistry
  • Immunohistochemistry-Paraffin 0.25 - 0.5 ug/ml
  • Immunofluorescence 0.5 - 1.0 ug/ml
• Application Notes: Hu-chromosome location: 6p21.3
  Molecular weight of antigen: 28kDa (beta chain)
  Immunohistochemistry-Paraffin 0.25 - 0.5 ug/ml for 30 minutes at RT; Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10 - 20 min followed by cooling at RT for 20 minutes. The 7mL size is a pre-diluted size and no additional dilutions are required before using this item for the intended application.

Packaging, Storage & Formulations

• Storage: Store at 4C.
• Buffer: 10 mM PBS with 0.05% BSA
• Preservative: 0.05% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: Protein A or G purified

Alternate Names for HLA-DR Antibody (LN-3)

• FLJ51114
• histocompatibility antigen HLA-DR alpha
• HLA class II histocompatibility antigen, DR alpha chain
• HLADR
• HLA-DR
• HLA-DRA
• HLA-DRA1
• major histocompatibility complex, class II, DR alpha
• MHC cell surface glycoprotein
• MHC class II antigen DRA
• MHC Class II DR
• MLRW

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: HLA-DRA
• Uniprot:
  • P01911(Human)